Domzalski David - Insider Non-Derivative Transactions at VYNE Therapeutics Inc. (VYNE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 1, 2024, Domzalski David's relationship to VYNE Therapeutics Inc. (VYNE) is Director,Officer (PRESIDENT AND CEO), and currently has 497,654 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other VYNE insiders.

Data Source: SEC.
Domzalski David - Insider Non-Derivative Transactions of VYNE Common Stock
Domzalski David - Insider Non-Derivative Transactions at VYNE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 2, 2024 F -- (Common Stock) 935 1.92 497654
Jun 1, 2024 Acquisition -- (Common Stock) 4429 2.16 498589
Apr 2, 2024 F -- (Common Stock) 1004 3.08 494160
Jan 3, 2024 F -- (Common Stock) 1004 2.28 495164
Jan 2, 2024 Acquisition -- (Common Stock) 225000 0 496168
Dec 14, 2023 Acquisition -- (Common Stock) 225000 0 271168
Dec 1, 2023 Acquisition -- (Common Stock) 2284 2.81 46168
Oct 3, 2023 F -- (Common Stock) 8549 3.83 43884
Jul 1, 2023 F -- (Common Stock) 981 4.1 52433
Jun 1, 2023 Acquisition -- (Common Stock) 2766 3.46 53414
Apr 1, 2023 F -- (Common Stock) 2734 3.08 50648
Jan 1, 2023 F -- (Common Stock) 10685 0.15 1064290